Unlock instant, AI-driven research and patent intelligence for your innovation.

tp recombinant antigen and preparation method and application thereof

A technology for recombinant antigens and labeled antigens, which is applied in the field of immunoassays, can solve the problems that the proportion of labels cannot be reduced too low, the specificity of the amount of labeled antigens used is reduced, and the prokaryotic expression lacks post-translational modification functions, etc.

Active Publication Date: 2020-01-17
FAPON BIOTECH INC +1
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] 1. When the markers are small markers such as enzymes, luminescent substances, radioactive substances, etc., in order to improve the sensitivity, it is necessary to increase the labeling ratio, but if the ratio is too high, the labeled antigen will be wrapped by the marker, so that the antigenic epitope will be embedded. lead to a decrease in antigenic activity;
[0008] 2. When the marker is a larger nanoparticle such as colloidal gold, latex or other nanoparticle markers, the theoretically optimal sensitivity state is that the lower the labeling ratio, the higher the sensitivity, and the sensitivity is when the molar ratio is 1:1 The highest, but due to the low amount of labeled antigen in the direct labeling process, it will lead to difficult labeling factors such as labeling precipitation, so that the labeling ratio cannot be reduced too low, resulting in low sensitivity, and the increase in the amount of labeled antigen will also lead to specificity reduce
However, prokaryotic expression lacks the post-translational modification function, and sometimes it needs to be expressed together with a special protein partner and further renaturation treatment or storage buffer is explored to make the protein activity better.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • tp recombinant antigen and preparation method and application thereof
  • tp recombinant antigen and preparation method and application thereof
  • tp recombinant antigen and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0049] Such as figure 1 The preparation method of the above-mentioned TP recombinant antigen shown comprises the following steps:

[0050] S10, providing a gene expression vector.

[0051] The gene expression vector is used to express the TP recombinant antigen. The TP recombinant antigen includes a chimeric expression polypeptide and a flexible link peptide that facilitates soluble expression. The chimeric expression polypeptide is a TPN15-TPN17-TPN47 chimeric expression polypeptide.

[0052] Preferably, when the TP recombinant antigen is used as a labeled antigen, it also includes a GST tag, and the GST tag, the chimeric expressed polypeptide and the flexible link peptide are sequentially connected.

[0053] Specifically, the TPN15-TPN17-TPN47 chimeric expression antigen is: (a), a polypeptide encoded by a polynucleotide consisting of the nucleotide sequence shown in SEQ ID No.1; (b), the same as SEQ ID No. The polynucleotide composed of the nucleotide sequence shown in 1 ...

Embodiment 1

[0086] Preparation of coating, labeling antigen, immune source and screening antigen of hybridoma cells.

[0087] Through literature review and bioinformatics analysis of the dominant epitopes of Treponema pallidum TpN17 (GeneBank No: M74825), TpN15 (GeneBank No: U73115.1), TpN47 (GeneBank No: NC_000919.1) genes, overlapping PCR primers were designed to artificially synthesize TpN17 ( 23aa-106aa), TpN15(31aa-109aa), TpN47(185aa-410aa) corresponding active segments, amplified by bridge PCR and introducing a flexible link peptide TRX that facilitates soluble expression to obtain a chimeric gene, the The gene was connected to the pMD18-T vector, transformed into Escherichia coli, single clone was picked, the correct positive plasmid was identified by PCR, and the plasmid was extracted and identified by enzyme digestion. The plasmids with correct PCR identification and enzyme digestion identification were sent for sequencing, and the results were completely consistent with the des...

Embodiment 2

[0093] Preparation of GST monoclonal antibody.

[0094] After dialyzing the recombinant GST protein solution obtained above with PBS, it was diluted to 1.0 mg / mL with PBS, mixed with an equal volume of Freund's complete adjuvant, and fully emulsified to obtain an oily emulsion. The emulsion was subcutaneously administered to the dorsal site of 6-week-old female BALB / c mice at a dose of 0.2 mL. 14 days after the first immunization, intraperitoneal booster immunization, that is, equal volumes of antigen and Freund’s incomplete adjuvant were mixed in equal volumes. After boosting immunization to four injections, tail blood was collected, serum was separated, and the titer was determined by indirect ELISA method. The titer was high It can be used for fusion at 1:10000. Three days before the fusion, the same dose of antigen mixed with an equal volume of 0.9% sodium chloride injection was injected intraperitoneally for booster immunization, and the immunization method was the same ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Login to View More

Abstract

The invention discloses a TP recombinant antigen and a preparing method and application thereof. The TP recombinant antigen comprises an embedded expression polypeptide and flexible linked peptide favorable for soluble expression connected in sequence; the embedded expression polypeptide is TPN15-TPN17-TPN47 embedded expression polypeptide. The TP recombinant antigen modifies the TPN15-TPN17-TPN47 embedded expression polypeptide by introducing the flexible linked peptide favorable for soluble expression, and the protein activity of the TP recombinant antigen is better compared with that of a traditional TP antigen.

Description

technical field [0001] The invention relates to the field of immune detection, in particular to a TP recombinant antigen and its preparation method and application. Background technique [0002] Syphilis is a sexually transmitted disease, and its pathogen is Treponema pallidum, also called Treponema pallidum (TP), which is mainly transmitted through sexual contact and blood, and produces a variety of symptoms and signs, which appear from time to time, and the course of the disease can vary. It lasts for a long time and can almost invade all organs of the body. It is a sexually transmitted disease that is second only to AIDS and seriously endangers the health of our people. It has been on the rise in my country in recent years. According to the 2014 syphilis key epidemic report, syphilis has ranked third in the number of reported incidences of Class B infectious diseases since 2009. ; Especially in the antenatal outpatient screening of pregnant women positive for syphilis ant...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K19/00C07K1/36C07K1/30C07K1/22C07K1/18C12N15/70G01N33/569
CPCC07K14/20C07K2319/23G01N33/56911G01N2333/20
Inventor 刘莉莉李瑞净
Owner FAPON BIOTECH INC
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More